BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 10692608)

  • 1. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.
    Porta M
    Pain; 2000 Mar; 85(1-2):101-5. PubMed ID: 10692608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache.
    Porta M
    Curr Rev Pain; 2000; 4(1):31-5. PubMed ID: 10998713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review.
    Lang AM
    Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
    De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
    Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
    Baker JS; Nolan PJ
    J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on botulinum toxin A injections of trigger points for myofascial pain.
    Zhou JY; Wang D
    Curr Pain Headache Rep; 2014 Jan; 18(1):386. PubMed ID: 24338700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
    Avendaño-Coy J; Gómez-Soriano J; Valencia M; Estrada J; Leal F; Ruiz-Campa R
    J Back Musculoskelet Rehabil; 2014; 27(4):485-92. PubMed ID: 24867895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of botulinum toxin in the treatment of chronic myofascial pain.
    De Andrés J; Cerda-Olmedo G; Valía JC; Monsalve V; Lopez-Alarcón ; Minguez A
    Clin J Pain; 2003; 19(4):269-75. PubMed ID: 12840622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
    Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome.
    Gottsch HP; Yang CC; Berger RE
    Scand J Urol Nephrol; 2011 Feb; 45(1):72-6. PubMed ID: 21062115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007533. PubMed ID: 22513950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of myofascial pain syndrome (MPS) with botulinum toxin type A (BoNT-A)].
    Günther O; Bitterlich N
    MMW Fortschr Med; 2011 Jul; 153 Suppl 2():64-9. PubMed ID: 23964470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
    Ojala T; Arokoski JP; Partanen J
    Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of PrabotulinumtoxinA (Nabota
    Kim DY; Kim JM
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for myofascial pain syndromes in adults.
    Soares A; Andriolo RB; Atallah AN; da Silva EM
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.